Zimmer Partners, LP Rhythm Pharmaceuticals, Inc. Transaction History

Zimmer Partners, LP

  • $5.18 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$21.39 - $49.64 $1.32 Million - $3.07 Million
61,800 New
61,800 $2.84 Million
Q1 2018

May 15, 2018
SELL
$19.9 - $32.25 $696,500 - $1.13 Million
-35,000 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$22.0 - $30.51 $770,000 - $1.07 Million
35,000
35,000 $1.02 Million

Others Institutions Holding RYTM

# of Institutions
178
Shares Held
69.1M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.86B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email